Capital International Investors’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,310,109	Closed	-$26.2M	–	436
2023 Q1	$26.2M	Hold	5,310,109	–	–	0.01%	373
2022 Q4	$33.4M	Hold	5,310,109	–	–	0.01%	350
2022 Q3	$57.3M	Buy	5,310,109 +982,767	+23%	+$13.4M	0.02%	328
2022 Q2	$49.3M	Buy	4,327,342 +3,740,264	+637%	+$33.2M	0.01%	346
2022 Q1	$5.35M	Sell	587,078 -992,031	-63%	-$10.3M	﹤0.01%	432
2021 Q4	$23.6M	Sell	1,579,109 -1,955,278	-55%	-$34.5M	0.01%	397
2021 Q3	$90.8M	Buy	3,534,387 +9,273	+0.3%	+$220K	0.02%	305
2021 Q2	$91.9M	Sell	3,525,114 -3,073,922	-47%	-$87.7M	0.02%	306
2021 Q1	$233M	Sell	6,599,036 -529,183	-7%	-$17.8M	0.06%	226
2020 Q4	$180M	Sell	7,128,219 -136,170	-2%	-$4.44M	0.05%	248
2020 Q3	$274M	Buy	7,264,389 +49,476	+0.7%	+$1.87M	0.08%	192
2020 Q2	$309M	Buy	7,214,913 +2,636,113	+58%	+$95.3M	0.1%	169
2020 Q1	$89M	Buy	4,578,800 +690,779	+18%	+$16.5M	0.04%	221
2019 Q4	$101M	Sell	3,888,021 -52,538	-1%	-$1.45M	0.03%	234
2019 Q3	$107M	Buy	3,940,559 +17	+0%	+$484	0.04%	221
2019 Q2	$106M	Buy	3,940,542 +1,908,988	+94%	+$53.2M	0.04%	234
2019 Q1	$58.7M	Hold	2,031,554	–	–	0.03%	259
2018 Q4	$54.7M	Buy	+2,031,554	New	+$54M	0.03%	241